R G Dluhy
Overview
Explore the profile of R G Dluhy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
1279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dluhy R, Anderson B, Harlin B, Ingelfinger J, Lifton R
J Pediatr
. 2001 May;
138(5):715-20.
PMID: 11343049
Objectives: To review the childhood course of glucocorticoid-remediable aldosteronism (GRA) in order to provide management guidelines for hypertension in children. Methods: Records for 20 children with GRA (aged 1 month...
2.
Wyckoff J, Seely E, Hurwitz S, Anderson B, Lifton R, Dluhy R
Hypertension
. 2000 Feb;
35(2):668-72.
PMID: 10679515
Glucocorticoid-remediable aldosteronism (GRA) is a hereditary form of primary hyperaldosteronism that presents with hypokalemia and hypertension from childhood onward. GRA is characterized by the ectopic production of aldosterone in the...
3.
Dluhy R, Lifton R
J Clin Endocrinol Metab
. 1999 Dec;
84(12):4341-4.
PMID: 10599685
No abstract available.
4.
5.
6.
The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management
Kennedy J, Dluhy R
Yale J Biol Med
. 1998 Nov;
70(5-6):565-75.
PMID: 9825485
Somatostatin receptors are present in the normal adrenal cortex and medulla. These receptors are also expressed by tumors that cause Cushing's syndrome and by pheochromocytomas. Somatostatin analogues such as octreotide...
7.
Dluhy R
J Allergy Clin Immunol
. 1998 May;
101(4 Pt 2):S447-50.
PMID: 9563370
Although hypothalamic-pituitary-adrenal (HPA) axis suppression has traditionally been viewed as an adverse event after long-term administration of corticosteroids, this effect can also be used to compare the potency of different...
8.
9.
Dluhy R
Respir Med
. 1998 Feb;
91 Suppl A:32-3.
PMID: 9474366
The potency of the inhaled corticosteroid, dose, duration of treatment, and the study subject receiving treatment all play a role in the effects observed on the HPA axis. At low/medium...
10.
Litchfield W, Anderson B, Weiss R, Lifton R, Dluhy R
Hypertension
. 1998 Feb;
31(1 Pt 2):445-50.
PMID: 9453343
There are anecdotal reports of early cerebrovascular complications occurring in patients with glucocorticoid-remediable aldosteronism (GRA). The issue has never been systematically evaluated. In this study, we retrospectively reviewed the International...